Phase II Study of AS1411 Combined With Cytarabine to Treat Acute Myeloid Leukemia [clinicaltrials:NCT00512083]
Phase II Study of AS1411 Combined With Cytarabine to Treat Acute Myeloid Leukemia [clinicaltrials:NCT00512083]
Bio2RDF identifier
NCT00512083
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00512083
identifiers.org URI
anticipated enrollment [clinicaltrials_vocabulary:anticipated-enrollment]
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
The overall aim of this ...... acute myeloid leukemia (AML).
brief title [clinicaltrials_vocabulary:brief-title]
Phase II Study of AS1411 Combined With Cytarabine to Treat Acute Myeloid Leukemia
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2007-08-06T00:00:00Z
intervention [clinicaltrials_vocabulary:intervention]
keyword [clinicaltrials_vocabulary:keyword]
Leukemia, Myeloid + Acute Disease
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2009-09-24T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00512083
number of arms [clinicaltrials_vocabulary:number-of-arms]
official title [clinicaltrials_vocabulary:official-title]
An Open Label Randomized Contr ...... elapsed Acute Myeloid Leukemia
org study id [clinicaltrials_vocabulary:org-study-id]
AS1411-C-201
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
primary completion date [clinicaltrials_vocabulary:primary-completion-date]
2009-04-01T00:00:00Z
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
2007-07-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2009-09-01T00:00:00Z
identifier
clinicaltrials:NCT00512083
title
Phase II Study of AS1411 Combined With Cytarabine to Treat Acute Myeloid Leukemia
@en
type
label
Phase II Study of AS1411 Combi ...... a [clinicaltrials:NCT00512083]
@en